Pilot Indocyanine Green Imaging for Mapping of Arm Draining Lymphatics & Nodes in Breast Cancer

Completed · Phase 2

Conditions studied: Breast Cancer

In brief

The purpose of this study is to determine if Indocyanine Green (IC-GREEN) is comparable to isosulfan blue (IS-BLUE) in the identification of arm lymphatics and arm-draining nodes during nodal staging procedures in breast cancer.

Key facts

Study ID

NCT01771666

Run by

Stanford University

People needed

23

Starts

2012-07-01

Expected to finish

2015-03-17

Last updated by the study team

2017-12-11

Who can join

Age: 18 and older, up to 90. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Ability to understand and the willingness to sign a written informed consent document.
• Signed written informed consent.
• Women undergoing sentinel lymph node biopsy.
• Women with breast cancer with known or suspected lymph node involvement.
• Women undergoing sentinel node identification and completion axillary lymph node dissection.
• Women of 18 years of age or older.
• Eastern Cooperative Oncology Group (ECOG) or Karnofsky Performance Status 0,1,2.
• Complete Blood Count (CBC) and basic Metabolic Panel within 6 months

You may not qualify if…

• History of liver or kidney failure will not be eligible.
• Allergies to iodine containing products will not be eligible.
• Women who are pregnant will not be eligible.
• Psychiatric or addictive disorders or other conditions that, in the opinion of the investigator, would preclude the patient from meeting the study requirements.

Where it is running

• Stanford University, School of Medicine — Stanford, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.